Hamner Institutes and China Medical City Create Rx-Development Institute in North Carolina | GenomeWeb

ATLANTA — The non-profit Hamner Institutes for Health Sciences and China Medical City inked an agreement yesterday creating a new drug-development institute intended to create a biotechnology bridge between North Carolina and China.

The new institute, called the Hamner-China Medical City Institute for International Drug Development, will receive $5 million from Chinese-American CRO Newsummit Biopharma, and will attempt to leverage each partner's strengths in translational research, business development, and education to produce new biomedical technologies.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.

Technology Review points out that a new US presidential science advisor hasn't been selected.

Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.

President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.